SK Inc., as the strategic investment holding company of SK Group, focuses its investments on four key areas: Advanced Materials, Biopharmaceuticals, Green, and Digital. The firm's strategy is centered on fostering sustainable growth, securing future growth engines, and enhancing corporate value through portfolio rebalancing and an ESG-oriented approach.
38% of their portfolio is in Climate & Energy. Average disclosed round size is $336.7M (across 7 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CCenter for Breakthrough Medicines | Unknown | $350M | Jan 2025 |
 Wildtype | Unknown | $7M | Nov 2022 |
 Atom Power | Growth | $100M | Aug 2022 |
| CCenter for Breakthrough Medicines | Growth | $350M | Jan 2022 |
 Nature's Fynd | Series C | $350M | Jul 2021 |
 Monolith Materials, Inc. | Unknown | — | Jun 2021 |
| PPolestar | Unknown | $550M | Apr 2021 |
 TerraPower | Growth | $650M | — |
Top Co-Investors
NVentures1 shared
SK Group1 shared
SoftBank Vision Fund1 shared
Hillhouse Capital1 shared
Balyasny Asset Management1 shared
EDBI1 shared
Breakthrough Energy Ventures1 shared
Generation Investment Management1 shared
1955 Capital1 shared
Danone Manifesto Ventures1 shared
ADM1 shared
NextEra Energy Resources1 shared
Perry Creek Capital1 shared
Azimuth Capital Management1 shared
Warburg Pincus1 shared
Last updated: 15 April 2026